Newsroom

Boehringer Ingelheim successfully obtained another interim injunction from the UK High Court against Dr Reddy, reinforcing its patent rights in ongoing pharmaceutical litigation. The article outlines the case details, the court’s reasoning, and what this decision means for patent enforcement in the UK.

Summary A recent EPO Boards of Appeal decision, T 0136/24, has examined the issue of "reasonable expectation of success" when the prior art discloses a protocol to an ongoing phase 3 clinical trial.

In the recent Decision T 2387/22, the Board's key message was: if you define an invention by a "relative improvement" of a known technical effect, the improvement must be expressed in "objectively...

EIP is proud to be featured in The Times Best Law Firms 2026, a prestigious list based on peer recommendations across the legal industry. This recognition highlights EIP’s commitment to technical excellence, client-focused service, and innovative IP strategies. From high-value patent litigation to strategic portfolio management, EIP continues to deliver results that matter for clients in technology, life sciences, and engineering. This accolade reinforces our position as a trusted leader in intellectual property law.

When it comes to technology, EIP has always been ahead of the curve; we are proud to announce the evolution of our IT department into a dedicated Tech & AI function, marking a bold step towards...

We are proud to share that we've been shortlisted for The British Legal Awards 2025 in the newly introduced category: ‘IP Team of the Year'! A special shout-out to our fantastic Litigation team,...